| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 1 | IT 1 | 99.44 |
| Cardiac Imaging and Diagnostics | Lifetime | 47 | IT 3 | 99.89 |
| Coronary Interventions and Diagnostics | Lifetime | 44 | IT 3 | 99.82 |
| Acute Myocardial Infarction Research | Lifetime | 75 | IT 2 | 99.76 |
| Cardiovascular Function and Risk Factors | Lifetime | 168 | IT 8 | 99.66 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 71 | IT 3 | 99.32 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 113 | IT 9 | 99.40 |
| Cardiovascular Disease and Adiposity | Lifetime | 155 | IT 6 | 99.13 |
| Pain Management and Treatment | Lifetime | 43 | IT 2 | 98.67 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 343 | IT 19 | 99.11 |
| Cardiac Ischemia and Reperfusion | Lifetime | 162 | IT 6 | 98.69 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 373 | IT 16 | 98.96 |
| Cardiac Health and Mental Health | Lifetime | 158 | IT 4 | 98.59 |
| Cardiac Structural Anomalies and Repair | Lifetime | 343 | IT 13 | 98.93 |
| Heart Rate Variability and Autonomic Control | Lifetime | 402 | IT 34 | 98.58 |
| Cardiovascular Issues in Pregnancy | Lifetime | 186 | IT 4 | 98.22 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 612 | IT 41 | 98.36 |
| Cardiac Valve Diseases and Treatments | Lifetime | 690 | IT 58 | 98.65 |
| Cardiomyopathy and Myosin Studies | Lifetime | 371 | IT 22 | 97.92 |
| Lipoproteins and Cardiovascular Health | Lifetime | 403 | IT 14 | 98.30 |
| Cardiac pacing and defibrillation studies | Lifetime | 526 | IT 25 | 98.47 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 495 | IT 20 | 97.92 |
| Cardiac Arrhythmias and Treatments | Lifetime | 787 | IT 31 | 98.11 |
| Blood Pressure and Hypertension Studies | Lifetime | 756 | IT 49 | 97.92 |
| Cardiac Fibrosis and Remodeling | Lifetime | 186 | IT 6 | 97.19 |
| Heart Failure Treatment and Management | Lifetime | 625 | IT 31 | 97.75 |
| Cardiovascular Effects of Exercise | Lifetime | 491 | IT 34 | 97.31 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 462 | IT 36 | 95.91 |
| Coronary Artery Anomalies | Lifetime | 395 | IT 19 | 96.58 |
| Pericarditis and Cardiac Tamponade | Lifetime | 240 | IT 26 | 94.00 |
| Inflammasome and immune disorders | Lifetime | 736 | IT 50 | 94.16 |
| Health and Medical Research Impacts | Lifetime | 456 | IT 4 | 91.99 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 786 | IT 43 | 94.41 |
| Heart rate and cardiovascular health | Lifetime | 93 | IT 12 | 93.37 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 701 | IT 71 | 89.60 |
| Aortic Thrombus and Embolism | Lifetime | 420 | IT 10 | 76.68 |
| Academic Publishing and Open Access | Lifetime | 732 | IT 17 | 52.92 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 21 | IT 3 | 99.76 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 1 | IT 1 | 99.08 |
| Acute Myocardial Infarction Research | 2021-2025 | 15 | IT 3 | 99.60 |
| Coronary Interventions and Diagnostics | 2021-2025 | 17 | IT 3 | 99.66 |
| Cardiac Health and Mental Health | 2021-2025 | 11 | IT 1 | 98.82 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 17 | IT 3 | 99.36 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 59 | IT 4 | 99.59 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 34 | IT 7 | 98.75 |
| Health and Medical Research Impacts | 2021-2025 | 10 | IT 1 | 97.02 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 105 | IT 8 | 99.03 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 40 | IT 2 | 97.27 |
| Heart Failure Treatment and Management | 2021-2025 | 113 | IT 12 | 98.71 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 90 | IT 8 | 97.72 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 148 | IT 15 | 98.09 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 258 | IT 33 | 98.25 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 289 | IT 13 | 97.10 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 184 | IT 14 | 97.45 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 153 | IT 13 | 93.85 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 361 | IT 34 | 97.15 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 253 | IT 32 | 96.35 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 169 | IT 9 | 95.31 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 272 | IT 17 | 95.59 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 824 | IT 58 | 93.71 |
| Viral Infections and Immunology Research | 2021-2025 | 250 | IT 29 | 91.60 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 162 | IT 6 | 92.78 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 113 | IT 9 | 92.15 |
| Congenital Heart Disease Studies | 2021-2025 | 430 | IT 20 | 93.12 |
| Cardiovascular Effects of Exercise | 2021-2025 | 288 | IT 51 | 92.69 |
| Diabetes Treatment and Management | 2021-2025 | 901 | IT 66 | 91.09 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 976 | IT 24 | 90.74 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 716 | IT 33 | 86.39 |
| Inflammasome and immune disorders | 2021-2025 | 539 | IT 27 | 87.24 |
| Climate Change and Health Impacts | 2021-2025 | 994 | IT 16 | 87.24 |
| Peripheral Artery Disease Management | 2021-2025 | 765 | IT 43 | 85.41 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 179 | IT 5 | 82.22 |
| Coronary Artery Anomalies | 2021-2025 | 361 | IT 31 | 80.33 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 205 | IT 58 | 75.20 |
| Meta-analysis and systematic reviews | 2021-2025 | 503 | IT 8 | 80.25 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 785 | IT 122 | 78.71 |
| Cardiac and Coronary Surgery Techniques | 2021-2025 | 483 | IT 33 | 75.31 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 676 | IT 72 | 70.66 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 745 | IT 21 | 65.93 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 659 | IT 29 | 62.16 |
| Potassium and Related Disorders | 2021-2025 | 646 | IT 47 | 62.88 |
| Academic Publishing and Open Access | 2021-2025 | 141 | IT 6 | 60.57 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 520 | IT 56 | 54.50 |
| Sex and Gender in Healthcare | 2021-2025 | 781 | IT 38 | 38.72 |